This inventor holds 46 USPTO granted patents and 19 published patent applications and 13 EPO patents, primarily in Analyte Monitoring Systems. Top assignee: Abbott Diabetes Care Inc.. Active years: 2013-2026.
Company Filing History:
Years Active: 2013-2026
Areas of Expertise:
Title: Innovations in Diabetes Care: The Patents of Glenn Howard Berman
Introduction
Glenn Howard Berman is an accomplished inventor based in Alameda, California, known for his significant contributions to the field of diabetes care. With a remarkable portfolio of 40 patents, Berman has dedicated his career to innovating and enhancing diabetes management through advanced technology.
Latest Patents
Among his latest advancements is a patent titled "Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance." This system and method provide critical guidance for diabetes therapy by determining glycemic risks through comprehensive analysis of glucose data. It includes the visualization of glucose medians, variability in glucose levels, and the risk of hypoglycemia. The Advanced Daily Patterns report generated by the system features a visualization of ambulatory glucose profiles and glucose control measures, presenting a clear and understandable display of a patient's glucose condition categorized into low glucose, median glucose, and glucose variability.
Career Highlights
Berman’s tenure at Abbott Diabetes Care Inc. marks a significant period in his career, where he has played a vital role in developing groundbreaking solutions for diabetes management. His innovative spirit and thorough understanding of glucose monitoring have led to advancements that improve patient outcomes and enhance the quality of care in diabetes treatment.
Collaborations
Throughout his career, Glenn Berman has collaborated with notable professionals in the field, including Kenneth J Doniger and Mark Kent Sloan. These collaborations have fueled the development of advanced technologies and methodologies, further showcasing the importance of teamwork in achieving innovation in healthcare.
Conclusion
In conclusion, Glenn Howard Berman's contributions to diabetes care through his numerous patents underscore his role as a key inventor in the field. Through continuous innovation and collaboration, Berman is making a lasting impact in the lives of individuals managing diabetes, advancing the science of glycemic monitoring and therapy guidance. His work at Abbott Diabetes Care Inc. reflects a commitment to improving health outcomes through technology and research.